Pfizer (PFE) reported Q1 FY 2021 earnings of $0.93 per share (versus $0.80 per share in Q1 FY 2020), beating analysts’ consensus estimate of $0.78 per share.

The company’s quarterly revenues amounted to $14.582 bln (+44.6% y/y), beating analysts’ consensus estimate of $13.408 bln.

The company also issued upside guidance for FY 2021, projecting EPS of $3.55-3.65 versus analysts’ consensus estimate of $3.23 and prior guidance of $3.10-3.20 and revenues of $70.5-72.5 bln versus analysts’ consensus estimate of $60.17 bln and prior guidance of $59.4-61.4 bln.

PFE rose to $40.60 (+1.93%) in pre-market trading.